ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NAS North Atlantic Smaller Companies Investment Trust Plc

3,770.00
-10.00 (-0.26%)
17 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
North Atlantic Smaller Companies Investment Trust Plc LSE:NAS London Ordinary Share GB0006439003 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -10.00 -0.26% 3,770.00 3,770.00 3,800.00 3,780.00 3,770.00 3,780.00 10,597 16:29:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 11.28M 2.15M 0.1617 233.15 502.11M
North Atlantic Smaller Companies Investment Trust Plc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker NAS. The last closing price for North Atlantic Smaller C... was 3,780p. Over the last year, North Atlantic Smaller C... shares have traded in a share price range of 3,500.00p to 4,400.00p.

North Atlantic Smaller C... currently has 13,283,338 shares in issue. The market capitalisation of North Atlantic Smaller C... is £502.11 million. North Atlantic Smaller C... has a price to earnings ratio (PE ratio) of 233.15.

North Atlantic Smaller C... Share Discussion Threads

Showing 451 to 474 of 625 messages
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older
DateSubjectAuthorDiscuss
16/9/2022
15:05
Dollar earners where most costs are in $ are a little better.
UK HQ, earnings and most costs in $.
Growth area in utilities (it does exist).
Inflation pass through.
Capital light.
Subscription model.
Long contracts.
High switching costs.
Looking towards new global opps as ROW follows NA.
Network effects helping growth rate.

p1nkfish
16/9/2022
14:55
Indeed. Free money for the brokers when interest rates rise, but hit elsewhere. Banks have the added political angle.

Personally, I don't see many winners in a rising inflation/rising interest rate environment, coupled with a bear market. Dollar earners, so far, but the dollar is approaching bubble territory.

The old staples of utilities and tobacco now too over-geared and politicised. Real chance some of the big water co's could get in trouble IMO.

Some co's will be able to pass on cost increases, but that's to counter cost increases, by definition.. Wages, energy etc will all be on the rise.

No, I want a wider discount on NAS :) We're a long way from the despair stage on equities atm.

spectoacc
16/9/2022
14:49
brokers are normally a disaster in bear market. Banks do better with steeper yeild curve but loan defaults can kill them.
loglorry1
16/9/2022
14:41
Banks, and share brokers (AJB, HL) ought to do well, but "well" is relative - make easy millions on customer deposits, but hit in other ways.
spectoacc
16/9/2022
13:40
I can't think of anything untouched by rates but the extent matters a lot. High quality companies with pricing power should largely pass on cost increases. Companies with lots of cash will earn more on cash deposits. Companies with tangible asset backing should see that asset backing rise. Companies with large pension deficits might see these deficits erased with rising discount rates. Health care or legal claims busiesses not so badly affected.

I can't imagine stuff like MORE gets away but perhaps a lot in the price. I'm sure Mills was well aware that this was around the corner so lets hope he was well paid enough to be well positioned.

loglorry1
16/9/2022
12:06
Personally I'd want the discount to widen - know it's large, but always is. These markets haven't knocked it out further yet.

Would also be intrigued to know which industries are "..Unaffected by rising interest and inflation rates".. If you sell something, & employ people, you're affected.

spectoacc
16/9/2022
12:03
It is a relatively safe haven for the patient. Have held for quite a while and certainly won't be selling.

Other point is reference to restart of buybacks - possibly - so some floor on price by the company.

p1nkfish
16/9/2022
11:37
Expanding @p1nkfish's quote above:


"There is no question that the value is, once again, opening up in equity markets and it is therefore expected that further new investments will be made over the coming months. It will be important to emphasise industries which will be unaffected by rising interest and inflation rates. We do expect the market, as a whole, to weaken further but we would hope to outperform this trend given our conservative balance sheet and the likelihood of further uplifts from our private equity portfolio."

spectoacc
16/9/2022
11:29
Given all the macro stuff going on I consider NAS to be a safe hiding place. I have others too. I’d like to be doing more buys of my own if we get one more down leg from the macro.
steve3sandal
16/9/2022
11:16
Release today, comment "We do expect the market, as a whole, to weaken further........"
p1nkfish
08/9/2022
06:30
Agreed - very specific skillset with no obvious investing background. But if she is a challenging mindset, hopefullly the diversity of thought as well as gender is increased.
18bt
06/9/2022
16:21
Interesting new NED.
p1nkfish
11/8/2022
10:08
It's proof of pudding time for Renalytx. If they can sell it then it will be worth a fortune. If not the costs and death spiral will kill it. Too late now to reduce costs - it either works or not and if it works these costs will be a drop in the bucket.

I assume Mills has sized his position accordingly.

KidneyIntelXTM is designed to diagnose and improve clinical management of patients with Type II diabetes with fast-progressing kidney disease, in an effort to curtail the estimated $114 billion annual cost1 of chronic and end-stage kidney disease to the United States healthcare system. The diagnostic will use machine learning algorithms to assess the combination of predictive blood-based biomarkers, including sTNFR1, sTNFR2 and KIM1, in combination with electronic health record information, to identify progressive kidney disease. KidneyIntelXTM is being developed in close collaboration with the Mount Sinai Health System.

loglorry1
11/8/2022
08:40
needs to get a grip on costs at Renx, remuneration is enormous considering the loss-making nature of the operation at present.
c3479z
10/8/2022
12:23
Focus matters and no matter how good someone is there is a limit to how much a person can focus on at one time.
p1nkfish
10/8/2022
11:17
Renalytx is a tough one. The upside is enormous if it works as they say it does. It wouldn't surprise me if it came good but having said that the last funding round was a disaster.
loglorry1
10/8/2022
11:06
He doesn't just hold Renx he's the Chairman. I think he's taken his eye of the ball on that holding for sure. Possibly needs to stick to just running the fund without the extra duties
mr roper
10/8/2022
10:00
Certainly better than me but with Rockwood + other stuff something will end up taking a back seat.
p1nkfish
10/8/2022
08:07
I don't think Mills has lost it. He went into this downturn in small-caps holding a lot of cash and USD cash as well. He resisted the temptation to pile into a lot of junk when it was flying up too. The NAV has been hit which would be impossible to avoid given he has to invest in small caps.

I take issue with some of the things he holds. Renalytx with a death spiral for example but I have to trust he knows what he is doing by and large and is much better than I could be in this space.

loglorry1
10/8/2022
08:02
Anyone think Mills has taken his hands off the tiller with age and other distractions?
p1nkfish
09/8/2022
08:36
crestchic coming through for them, today...
c3479z
22/6/2022
07:13
* Resolution 14 was put to the Meeting as a resolution of the independent shareholders of the Company. As a result, 9,455,336 of the ordinary shares in issue were eligible to vote on this resolution, these shares not being held by the Concert Party (as defined in the Notice). The waiver of Rule 9 granted by Resolution 14 permits the Concert Party's interest in the Company's shares to increase from 30.78% to a maximum of 34.21% (in each case representing 4,205,664 ordinary shares) as a result of the share buyback authorised by Resolution 12 without requiring the Concert Party to make a mandatory offer for the other shareholders' shares. The results of the poll vote on this Resolution 14 were 2,502,293 votes for, 1,132,052 against, 3,729,299 abstentions, therefore with 68.85% in favour of the resolution.
steve3sandal
21/6/2022
21:45
Thanks P56, fully support, but I imagine nothing will change.
steve3sandal
21/6/2022
15:23
At today's AGM, a "large-holding & long-time" private investor
a) requested the NEW Chairman to initiate a more proactive policy to buybacks (i.e. rather than passively wait for a seller to ALSO actively go into the market as a buyer )
b) told Chris Mills (CEO & IM) that, when CM eventually decides to retire (now 69), there should be a tender-offer (liquidation??) at close to NAV rather than just a hand-over of the reins to his son Nick.

peckers56
Chat Pages: 25  24  23  22  21  20  19  18  17  16  15  14  Older

Your Recent History

Delayed Upgrade Clock